trial · primary record
mocravimod
Adult Acute Myeloid Leukemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 366 |
| Primary completion | 2029-11 |
| Primary endpoint | Relapse-free survival (RFS) |
| Registry ID | NCT05429632 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:39.889Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05429632
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.